Comprehensive Care Strategies for Managing Xylazine-Associated Wounds

Overview

Xylazine, increasingly found as an adulterant in illicit fentanyl, is linked to distinctive, often chronic wounds primarily on extremities. These wounds pose significant clinical challenges due to their necrotic nature and risk of superinfection, necessitating a multidisciplinary care approach.

Background

Xylazine is a veterinary tranquilizer and alpha-2 adrenergic agonist increasingly prevalent in the US illicit drug supply, especially in the Northeast. It is associated with unique wounds termed xylazine-associated wounds (XAWs), which differ from typical injection-related infections by often starting as necrotic ulcers rather than cellulitis or abscesses. Philadelphia remains the epicenter of xylazine-related morbidity, with a dramatic rise in wound care utilization and hospitalizations since 2020. Diagnosis is clinical, supported by urine testing where available, and requires differentiation from other skin and soft tissue infections.

Data Highlights

Key Findings

• XAWs often present as large, chronic wounds with full-thickness necrosis and may expose tendons or bones.
• Two types of XAWs exist: those near injection sites starting as blisters/bruises and those distant from injection sites, sometimes related to snorting or smoking.
• Early-stage XAWs are typically noninfected, contrasting with heroin-related skin infections that begin as cellulitis or abscesses.
• Multidisciplinary care involving addiction medicine, wound care, infectious diseases, surgery, and peer navigation is critical for effective management.
• Avoid aggressive debridement; empirical antibiotics targeting MRSA and group A Streptococcus are recommended, with oral trimethoprim-sulfamethoxazole and β-lactams respectively.
• Intravenous daptomycin is preferred over vancomycin to reduce phlebotomy burden, and contingency antibiotic plans including linezolid, tedizolid, or dalbavancin facilitate patient-directed discharge.

Clinical Implications

Clinicians should recognize the distinctive presentation of XAWs and incorporate multidisciplinary strategies including addiction treatment and wound care. Empirical antibiotic regimens should target common pathogens like MRSA and GAS, while avoiding overly aggressive surgical debridement. Use of intravenous daptomycin can improve patient comfort and adherence by minimizing blood draws.

Conclusion

Xylazine-associated wounds represent a growing clinical challenge linked to the evolving illicit drug supply. Comprehensive, multidisciplinary care tailored to the unique pathophysiology of these wounds is essential to improve outcomes and reduce morbidity among affected persons who use drugs.

References

1. Harris et al. 2023 -- Comprehensive Care Strategies for Managing Wounds Related to Xylazine Use